Stay updated with breaking news from Alina Cocuzza. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
THE WOODLANDS, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its first quarter 2024 financial results on Thursday, May 2, 2024 after the markets
THE WOODLANDS, Texas, April 29, 2024 -- Lexicon Pharmaceuticals, Inc. today announced that Lonnel Coats has provided notice of his retirement as chief executive officer and as a member of its...
THE WOODLANDS, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that four data presentations related to sotagliflozin, an inhibitor of two sodium glucose transport
Commercial launch of INPEFA® continues to progress. with increasing demand across the cardiology community and improving payer access Patient enrollment underway in PROGRESS, a Phase 2b study of...
THE WOODLANDS, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) ("Lexicon") today announced it has entered into a securities purchase agreement (the "purchase agreement") for a